These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 19015227)
21. Characterisation of autoantibodies to peripheral myelin protein 22 in patients with hereditary and acquired neuropathies. Ritz MF; Lechner-Scott J; Scott RJ; Fuhr P; Malik N; Erne B; Taylor V; Suter U; Schaeren-Wiemers N; Steck AJ J Neuroimmunol; 2000 May; 104(2):155-63. PubMed ID: 10713355 [TBL] [Abstract][Full Text] [Related]
22. Detection and quantification of antibodies to the extracellular domain of P0 during experimental allergic neuritis. Archelos JJ; Roggenbuck K; Schneider-Schaulies J; Toyka KV; Hartung HP J Neurol Sci; 1993 Jul; 117(1-2):197-205. PubMed ID: 7691994 [TBL] [Abstract][Full Text] [Related]
23. Pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy. Hughes RA; Allen D; Makowska A; Gregson NA J Peripher Nerv Syst; 2006 Mar; 11(1):30-46. PubMed ID: 16519780 [TBL] [Abstract][Full Text] [Related]
25. Antibodies to the Caspr1/contactin-1 complex in chronic inflammatory demyelinating polyradiculoneuropathy. Pascual-Goñi E; Fehmi J; Lleixà C; Martín-Aguilar L; Devaux J; Höftberger R; Delmont E; Doppler K; Sommer C; Radunovic A; Carvajal A; Smyth S; Williams L; Mazanec R; Potočková V; Hinds N; Cassereau J; Viala K; Lefilliatre M; Nicolas G; Foley P; Leypoldt F; Keddie S; Lunn MP; Zimprich F; Nunkoo VS; Löscher WN; Martínez-Martínez L; Díaz-Manera J; Rojas-Garcia R; Illa I; Rinaldi S; Querol L Brain; 2021 May; 144(4):1183-1196. PubMed ID: 33880507 [TBL] [Abstract][Full Text] [Related]
26. Analysis of anti-ganglioside antibodies by a line immunoassay in patients with chronic-inflammatory demyelinating polyneuropathies (CIDP). Klehmet J; Märschenz S; Ruprecht K; Wunderlich B; Büttner T; Hiemann R; Roggenbuck D; Meisel A Clin Chem Lab Med; 2018 May; 56(6):919-926. PubMed ID: 29329103 [TBL] [Abstract][Full Text] [Related]
27. Chronic inflammatory demyelinating polyradiculoneuropathy and variants: where we are and where we should go. Nobile-Orazio E J Peripher Nerv Syst; 2014 Mar; 19(1):2-13. PubMed ID: 24612201 [TBL] [Abstract][Full Text] [Related]
28. Pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy. Rezania K; Gundogdu B; Soliven B Front Biosci; 2004 Jan; 9():939-45. PubMed ID: 14766420 [TBL] [Abstract][Full Text] [Related]
35. Immune mechanisms in spontaneously occurring CIDP in NOD mice. Soliven B J Peripher Nerv Syst; 2011 Jun; 16 Suppl 1():56-9. PubMed ID: 21696501 [TBL] [Abstract][Full Text] [Related]
36. T helper type 2 like cytokine responses to peptides from P0 and P2 myelin proteins during the recovery phase of Guillain-Barré syndrome. Dahle C; Ekerfelt C; Vrethem M; Samuelsson M; Ernerudh J J Neurol Sci; 1997 Dec; 153(1):54-60. PubMed ID: 9455979 [TBL] [Abstract][Full Text] [Related]
39. Autoreactive T and B cells in nervous system diseases. Sun JB Acta Neurol Scand Suppl; 1993; 142():1-56. PubMed ID: 8382894 [TBL] [Abstract][Full Text] [Related]
40. [Peripheral nerve myelin antigen-specific T cells in human]. Ota K; Shimizu Y; Ueda M; Akiyama N; Iwata M Rinsho Shinkeigaku; 1996 Jul; 36(7):898-901. PubMed ID: 8952362 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]